BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5817479)

  • 1. [Fever reaction and the effect on antibody formation of vaccination with commercially available KL measles vaccine, with special reference take-rate of live vaccine and need for additional immunization].
    Santo K; Tatsumi H; Kato K; Hanaya T; Abe S
    Nihon Shonika Gakkai Zasshi; 1969 Apr; 73(4):594-9. PubMed ID: 5817479
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of the inoculation test of measles vaccine. 2. The results of the use of inactivated measles vaccine alone and combined inactivated and attenuated live virus vaccine].
    Santo K
    Nihon Shonika Gakkai Zasshi; 1967 Mar; 71(3):344-55. PubMed ID: 6070597
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on further attenuated live measles vaccine. 3. Selection of less reactive variants of CAM measles vaccine virus.
    Takaku K; Sasada T; Konobe T; Onishi K; Ueda S
    Biken J; 1970 Sep; 13(3):163-8. PubMed ID: 5530510
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anti-measles vaccination with the Schwarz hyperattenuated live vaccine; post-vaccinal virological study and serological examination for 2 years].
    Boué A; Celers J
    Pathol Biol; 1967 Jan; 15(1):65-70. PubMed ID: 5340408
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on further attenuated live measles vaccine. IV. Clinical and serological evaluation of a clone of CAM-CEF measles vaccine virus.
    Ueda S; Takahashi M; Kurimura T; Ogino T; Suzuki N
    Biken J; 1970 Sep; 13(3):169-74. PubMed ID: 5530511
    [No Abstract]   [Full Text] [Related]  

  • 6. [Development of measles vaccination in Austria].
    Huber EG; Rannon L
    Padiatr Padol; 1973; 8(3):247-56. PubMed ID: 4715034
    [No Abstract]   [Full Text] [Related]  

  • 7. Live measles vaccine prepared in dog kidney cells. 3. Vaccination against measles with Czechoslovak live vaccine.
    Adam E; Kratochvílova M; Mares I; Drevo M; Závadová H
    J Hyg Epidemiol Microbiol Immunol; 1966; 10(2):232-9. PubMed ID: 5330077
    [No Abstract]   [Full Text] [Related]  

  • 8. Effectiveness of mumps virus given alone or in combination with live vaccines against measles and rubella.
    Nasibov MN; Yakovleva NV; Smorodintsev AA
    Prog Immunobiol Stand; 1970; 4():676-82. PubMed ID: 5482205
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on further attenuated liver measles vaccine. VII. Development and evaluation of CAM-70 measles virus vaccine.
    Okuno Y; Ueda S; Kurimura T; Suzuki N; Yamanishi K
    Biken J; 1971 Sep; 14(3):253-8. PubMed ID: 5167868
    [No Abstract]   [Full Text] [Related]  

  • 10. [Measles vaccination with split vaccines and living vaccines (author's transl)].
    Stehr K; Enders-Ruckle G; Spiess H
    MMW Munch Med Wochenschr; 1975 Jul; 117(27):1159-64. PubMed ID: 808710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Live, attenuated mumps-virus vaccine.
    Hilleman MR; Buynak EB; Weibel RE; Stokes J
    N Engl J Med; 1968 Feb; 278(5):227-32. PubMed ID: 4169706
    [No Abstract]   [Full Text] [Related]  

  • 12. The development and the study of live measles vaccine from highly attenuated strain Enders-Schwarz-Chumakov (ESC).
    Chumakov MP; Voroshilova MK; Grachev VP; Dzagurov SG; Sinyak KM
    Prog Immunobiol Stand; 1967; 3():194-5. PubMed ID: 5379939
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on measles in Thailand. II. Field trials of measles vaccine, with special reference to the K-L method.
    Tsuchinda P; Jayavasu J; Sangkawibha N; Okuno Y; Ueda S
    Biken J; 1967 Sep; 10(3):135-41. PubMed ID: 6081222
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on further attenuated live measles vaccine. V. Immunization test of CAM-A4 measles vaccine on handicapped children.
    Ueda S; Okuno Y; Sakamoto Y
    Biken J; 1970 Sep; 13(3):175-8. PubMed ID: 4249672
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical immunoserological study of combined innoculation of inactivated and live measles vaccines].
    Yamazaki Y
    Nihon Shonika Gakkai Zasshi; 1969 May; 73(5):644-55. PubMed ID: 5817193
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on the persistence of immunity 14-15 years after vaccination with a live measles vaccine].
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):389-91. PubMed ID: 2598095
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunologic response and post-vaccination reactions in children vaccinated against measles. I. Assessment of post-vaccination reactions].
    Naruszewicz-Lesiuk D; Kańtoch M; Polna I
    Przegl Epidemiol; 1974; 28(3):315-24. PubMed ID: 4471837
    [No Abstract]   [Full Text] [Related]  

  • 18. Observation of the protective effect of live measles vaccines in the first year after vaccination.
    Sejda J; Helcl J; Strauss J
    J Hyg Epidemiol Microbiol Immunol; 1966; 10(3):288-95. PubMed ID: 4161911
    [No Abstract]   [Full Text] [Related]  

  • 19. [Measles vaccination of pre-school children: a detailed study of reaction frequency and side effects after immunization with vaccine of 3 different strengths].
    Böttiger M; Heller L; Kamensky P; Svanberg B
    Lakartidningen; 1974 Sep; 71(36):3270-4. PubMed ID: 4410083
    [No Abstract]   [Full Text] [Related]  

  • 20. Investigation and appplication of the USSR AMS live measles vaccine from the ESC strain for mass vaccination against measles.
    Chumakov MP; Voroshilova MK; Grachev VP; Sinyak KM; Boiko VM; Seibil VB; Rodin VI; Piven GG
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(1):1-18. PubMed ID: 4985647
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.